February 2016 Life Science Industry Research Reports

Male Hypogonadism – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Male Hypogonadism – Pipeline Review, H1 2016′, provides an overview of the Male Hypogonadism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Hypogonadism, complete with analysis by stage of development, drug […]

Influenza B Infections – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Influenza B Infections – Pipeline Review, H1 2016′, provides an overview of the Influenza B Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenza B Infections, complete with analysis by stage […]

Genital Herpes – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Genital Herpes – Pipeline Review, H1 2016′, provides an overview of the Genital Herpes pipeline landscape. The report provides comprehensive information on the therapeutics under development for Genital Herpes, complete with analysis by stage of development, drug […]

Epstein-Barr Viral Infections – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Epstein-Barr Viral Infections – Pipeline Review, H1 2016′, provides an overview of the Epstein-Barr Viral Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Epstein-Barr Viral Infections, complete with analysis by stage […]

Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2016′, provides an overview of the Ventilator Associated Pneumonia (VAP) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ventilator Associated Pneumonia (VAP), complete with […]

Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) – Pipeline Review, H1 2016′, provides an overview of the Hospital Acquired Pneumonia (HAP) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hospital Acquired Pneumonia (HAP), complete with […]

Candidiasis – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Candidiasis – Pipeline Review, H1 2016′, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of […]

Systemic Sclerosis (Scleroderma) – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) – Pipeline Review, H1 2016′, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic Sclerosis (Scleroderma), complete with analysis by stage […]

Myasthenia Gravis – Pipeline Review, H1 2016

Published in Feb 2016 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Myasthenia Gravis – Pipeline Review, H1 2016′, provides an overview of the Myasthenia Gravis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myasthenia Gravis, complete with analysis by stage of development, drug […]